Phosphagenix raises $4m in UK placement
Wednesday, 03 November, 2004
Phosphagenics (ASX:POH) has raised £1.75 million (AUD$4.3 million) through a placement of about 18 million shares in the UK.
It's the second placement the company has done in the UK this year -- in late July the company raised almost AUD$850,000 through a placement at the same time as it announced plans to list on the London Stock Exchange's Alternative Investment Market (AIM).
CEO Ian Patterson said the new placement indicated Phosphagenics' commitment to establishing itself as an international company and to listing on AIM. The funds will be used to accelerate and extend development of Phosphagenics' pharmaceutical program.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
